(and dosage form):
5 mL (= 1 medicine measure) contains 12,1 mg of dihydrocodeine bitartrate, and as preservatives 0,1% m/v methyl paraben and 0,02% m/v propyl paraben.
A.10.1 Antitussives and expectorants.
Antitussive cough sedative.
Paracodin syrup is particularly suitable for children.
All types of cough and cough irritation, particularly in inflammation of the respiratory tract.
Paracodin is therefore specially indicated in the following conditions: Bronchitis, whooping cough, tracheitis, pharyngitis, laryngitis, as well as in cough associated with emphysema and pulmonary tuberculosis.
Conditions associated with impaired respiratory function; long term administration in chronic constipation.
DOSAGE AND DIRECTIONS FOR USE:
If not otherwise prescribed by the physician:
Infants (4 - 12 months) 1 mL (¼ medicine measure);
Young children (1 - 5 years) 1 - 2,5 mL (¼ - ½ medicine measure);
Older children (6 - 12 years) 2,5 - 5 mL (½ - 1 medicine measure);
Adults 5 - 10 mL (1 - 2 medicine measures) up to 3 times a day.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Paracodin may lead to constipation, especially in small children.
Diabetics are reminded that 5 mL of Paracodin syrup contains about 1 g of glucose equivalent.
As with all other drugs acting on the central nervous system the consumption of alcohol should be avoided under Paracodin therapy.
Paracodin may impair the speed of patient's reaction (eg. in traffic), particularly when administered in high doses.
In accordance with present views on the use of drugs in pregnant women, prescription of Paracodin should be considered carefully during the first 3 months of pregnancy.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Drowsiness: retention of urine and faeces may occur which should be treated symptomatically according to the severity of the clinical picture.
A clear slightly yellowish solution.
Glass bottles containing 100 mL and 200 mL of syrup.
Store in a cool (below 30°C), dry place. Keep out of reach of children.
B1041 (Act 101/1965)
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
South Africa (Pty) Ltd.
P O Box 3030, Halfway House, 1685
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
1 March 1997
PC2-A1 100 Knoll logo
Updated on this site: December 2002
Source: Community Pharmacy
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2004